Company intelligence / Profile preview

Soovu Labs

Seattle, Washington, United Statessoovu.com ↗

Ownership: Private
Development stage: Commercial

Overview

Soovu Labs has developed and commercialized an FDA-registered wearable thermal neuromodulation system for rapid and lasting relief of chronic and musculoskeletal pain. Clinical trials have shown significant reduction in pain within 5 minutes of use with effects lasting up to 3.5–5.5 hours; after eight weeks of use, participants reported improvements in mobility, sleep, productivity, mood, and overall well-being.

Therapeutic areas: Women's HealthNeurologyRheumatology
Modalities: DeviceNon-pharmacological therapyDigital health platform (coaching/app)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

RelieVRx

Commercial

Indications: Chronic pain, Musculoskeletal pain, Menstrual pain, Low back pain, Arthritis

Partnerships

Cynergy Wellness Inc.

Beyond the preview

Go deeper on Soovu Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soovu Labs.

Explore the full profile